BioMedNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Reports Positive Preclinical Data on PH94B’s Mechanism of Action
Nov 12, 2020
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced new in vitro electrophysiology data. According to the update, the data demonstrate that the mechanism of action of PH94B, the intranasal neuroactive steroid the company is preparing for Phase 3 development as a potential acute rapid-onset treatment of anxiety in adults with social anxiety disorder, does not involve direct activation of GABA-A receptors, in distinct contrast to the mechanism of action of benzodiazepines (“benzos”), which act as direct positive modulators of GABA-A receptors. “We are very pleased with the results of these studies that suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such as sedation and cognitive impairment, or abuse liability,” stated VistaGen CEO Shawn K. Singh. “While benzodiazepines provide relief for many Americans struggling with anxiety, their extremely risky safety profile does not lend itself to long term use. The mechanism of action contributes to the safety profile. As we have seen in Phase 2 clinical studies, while PH94B is able to produce rapid-onset benzo-like, anti-anxiety effects, this study demonstrates that PH94B does not have a benzo-like mechanism of action. As we approach Phase 3 development of PH94B, especially given the FDA’s recent public announcement about safety concerns associated with benzo use, these new data make us even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos.”
To view the full press release, visit https://ibn.fm/mNCyV
About VistaGen Therapeutics
VistaGen is a clinical-stage biopharmaceutical company developing and commercializing differentiated new generation medicines that go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on Twitter, LinkedIn and Facebook.
NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Three people killed in Noney in Manipur
KIM alleged that the act was committed by cadres of the NSCN-IM and ZUF(K) terrorist groups. This atrocity is a direct, unprovoked assault on the lives, dignity, and survival of the Kuki-Zo people in their own homeland.
CCI clears five major deals across food, energy, fintech and telecom sectors
CCI has granted approval for five significant business transactions in sectors like food services and renewable energy. The merger of Sapphire Foods India Limited with Devyani International Limited aims to combine their restaurant operations in India. Aditya Birla Renewables Limited is set to acquire Solenergi Power Private Limited from Shell for approximately Rs 17,200 crore. In financial services, Prosus N.V.
CCI clears five major deals across food, energy, fintech and telecom sectors
CCI has granted approval for five significant business transactions in sectors like food services and renewable energy. The merger of Sapphire Foods India Limited with Devyani International Limited aims to combine their restaurant operations in India. Aditya Birla Renewables Limited is set to acquire Solenergi Power Private Limited from Shell for approximately Rs 17,200 crore. In financial services, Prosus N.V.
Trump's oil portfolio up 43% amid Big Oil windfall, pain at the pump
Major oil companies, including ExxonMobil, Chevron, and Shell, reported higher earnings in the third quarter. This comes as the conflict in Iran leads to increased fuel prices for American consumers. Trump's investments in oil and gas stocks have significantly appreciated during this time. More than 94% of his oil stock purchases occurred after the conflict began. Rising fuel prices serve as a crucial issue ahead of the upcoming midterm elections.
Ravi Shankar Prasad claims Nehru became PM through 'vote chori'
"What kind of mock parliament is this, in which only the opposition is present, and the ruling party is absent? While its (INDIA bloc's) leaders disrupt parliamentary proceedings in the House, the party is mocking parliament and the people of the country by staging such an exercise," Prasad told reporters at the Bihar BJP headquarters in Patna.
PM Modi slams Opposition, says it has turned into 'Avrodh Paksh'
Prime Minister Narendra Modi on Saturday accused the Opposition of obstructing national progress and attempting to divide the country, dubbing it "Avrodh Paksh" instead of "Virodh Paksh". Addressing Rashtriya Ekta Diwas celebrations in Gujarat, he also flagged infiltration, demographic changes and border security as key national priorities.
Michael Carrick Under Fresh Pressure After Manchester United's 2-0 Loss To Chelsea
Missed opportunities, a red card for Lisandro Martinez and a clinical Chelsea display condemned Manchester United to another damaging loss.
Above-normal maximum temperatures likely over most parts of India in November: IMD
The IMD noted that in November, below-normal rainfall is likely over most parts of the country except for some areas in central, northwest, and Northeast India, where normal to above-normal rainfall is likely.
Above-normal maximum temperatures likely over most parts of India in November: IMD
The IMD noted that in November, below-normal rainfall is likely over most parts of the country except for some areas in central, northwest, and Northeast India, where normal to above-normal rainfall is likely.
Delhi pollution restrictions from November 1: 50% WFH, parking charges to double, vehicle curbs and more; check full list under winter action plan
Delhi vehicle restrictions from November 1: The Delhi government will enforce various anti-pollution measures to improve air quality from November 1. From restricting older vehicles to banning dust-generating construction activities, the government has launched a winter action plan to combat the air pollution that chokes the city annually. Under the restrictions, parking charges will double to discourage the use of private vehicles and encourage public transport usage. Additionally, a 50% work-from-home policy will also be implemented in government and private offices during the winter months.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.